Condition
Mpox (Monkeypox) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Mpox (Monkeypox) clinical trials that are recruiting, at sites in 2 countries (most in Democratic Republic of the Congo (2), South Africa (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
mRNA vaccine (BNT166a) for mpox and smallpox prevention in adults in Africa
This tests whether two doses of the mRNA vaccine BNT166a are safe and produce an immune response in healthy adults in Africa, including people who have or have not had prior smallpox or mpox exposure.
-
See if LC16m8 mpox vaccine protects people in the DRC
This study tests whether the LC16m8 mpox vaccine helps prevent mpox in people aged 12 months and older in the DRC.
Related topics
Quick answers
How many Mpox (Monkeypox) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Democratic Republic of the Congo (2 trials), South Africa (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.